Another failure in search for treatment to slow Alzheimer's
Thursday, November 24, 2016
INDIANAPOLIS -- An experimental treatment for Alzheimer's failed again in a widely anticipated study, disappointing many who had hoped drugmaker Eli Lilly had found a way to slow the progression of the mind-robbing disease.
Subscribe below or log in with your password here.
For more than 115 years, the Southeast Missourian has written the first draft of local history. We have aspired to enrich, entertain, educate and inform. Our core values have remained firm: truth, service, quality, integrity and community. Support our mission.
Join today
Note: Special discounts available to new subscribers only. Print subscriptions may include up to 13 Premium Issues per year, which include special magazines. For each Premium Issue, your account balance will be charged an additional fee in the billing period when the section publishes. This will result in shortening the length of your billing period.